Royal Bank of Canada
CALA

Royal Bank of Canada’s Calithera Biosciences, Inc CALA Stock Holding History

Royal Bank of Canada’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-163
Closed -$7K – 8082
2021
Q2 		$7K Sell
163
-177
-52% -$7.78K ﹤0.01% 7005
2021
Q1 		$16K Buy
340
+291
+594% +$16.9K ﹤0.01% 6582
2020
Q4 		$5K Buy
+49
New +$4.29K ﹤0.01% 6693
2020
Q3 		– Sell
-7
Closed -$1K – 7122
2020
Q2 		$1K Sell
7
-5
-42% -$594 ﹤0.01% 6536
2020
Q1 		$1K Sell
12
-197
-94% -$23.5K ﹤0.01% 6559
2019
Q4 		$23K Buy
209
+164
+364% +$12.3K ﹤0.01% 5808
2019
Q3 		$3K Sell
45
-54
-55% -$4.32K ﹤0.01% 6239
2019
Q2 		$8K Buy
+99
New +$11.2K ﹤0.01% 6140
2019
Q1 		– Sell
-3
Closed – – 7240
2018
Q4 		$0 Sell
3
-31
-91% -$3.06K ﹤0.01% 7316
2018
Q3 		$4K Sell
34
-101
-75% -$9.62K ﹤0.01% 6368
2018
Q2 		$13K Sell
135
-186
-58% -$21.1K ﹤0.01% 5747
2018
Q1 		$40K Buy
321
+305
+1,906% +$47.6K ﹤0.01% 5159
2017
Q4 		$3K Sell
16
-142
-90% -$36.4K ﹤0.01% 6227
2017
Q3 		$49K Buy
158
+151
+2,157% +$47.6K ﹤0.01% 5432
2017
Q2 		$2K Buy
+7
New +$1.87K ﹤0.01% 6317
2017
Q1 		– Hold
0
– – – 6909
2015
Q4 		– Sell
-21
Closed -$2K – 6908
2015
Q3 		$2K Sell
21
-11
-34% -$1.43K ﹤0.01% 6406
2015
Q2 		$5K Buy
+32
New +$7.42K ﹤0.01% 6250

Other funds holding CALA

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DMPV
Delphi Management Partners VIII San Mateo, California $138M AUM 56.74% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Royal Bank of Canada's CALA Position: Q3 2021 in Review

Royal Bank of Canada sold out of Calithera Biosciences, Inc (CALA) in Q3 2021, closing a stake of 163 shares — an estimated $7K sold.

Royal Bank of Canada first reported a position in CALA in Q2 2015 and held it in 17 quarters. The position peaked at $49K in Q3 2017. 66 funds tracked by Wall St. Rank hold CALA as of Q3 2021.

  • Royal Bank of Canada reported no remaining Calithera Biosciences, Inc position as of Q3 2021 after selling out during the quarter.
  • Royal Bank of Canada sold 163 Calithera Biosciences, Inc shares in Q3 2021, an estimated $7K.
  • Royal Bank of Canada first reported a position in Calithera Biosciences, Inc in Q2 2015 and held it in 17 quarters.
  • Royal Bank of Canada's Calithera Biosciences, Inc position peaked at $49K in Q3 2017.
  • 66 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q3 2021.

Based on Royal Bank of Canada's 13F filing for Q3 2021, filed 15 Nov 2021.